BELLUS Health(BLU)

明白点儿了2021-09-21 05:34

$BELLUS Health(BLU)$ 黑马一匹查看全文

牛唐2021-09-20 11:40

最近加拿大的药股涨的不错$Aurinia制药(AUPH)$ 、$BELLUS Health(BLU)$ 、$AbCellera Biologics(ABCL)$查看全文

冷枪手假亦真2021-09-15 03:42

$BELLUS Health(BLU)$ 疫苗管用～就查看全文

冷枪手假亦真2021-09-14 22:55

$BELLUS Health(BLU)$ 真正疫苗股查看全文

产业链观察2021-09-13 19:48

药闻▶$BELLUS Health(BLU)$ 宣布BLU-5937 治疗难治性慢性咳嗽的 2b 期 SOOTHE 试验的积极中期分析，达到了临床疗效高概率的阈值。
SOOTHE 2b 期试验有望在第四季度提供顶线结果查看全文

美股律师郝俊波2021-03-17 14:40

$BELLUS Health(BLU)$ 【 BELLUS Health Inc(BLU)最新证券集体诉讼 】
BELLUS Health Inc (BLU)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2019年9月5日至2020年7月5日期间进行虚假陈述及未向投资者披露以下重大不利事实: (1) 就公司的业务、运营、药物生产、...查看全文

Alex19942021-02-23 03:10

$BELLUS Health(BLU)$ 开仓咯，下周一投资者大会，先上车查看全文

LAES1682021-02-19 09:15

$BELLUS Health(BLU)$ BLU转发 BELLUS Health, is also a clinical stage biopharma research company – but the focus here is on an issue that few of us ever think about. Hypersensitivity – the state of being highly, or even excessively, sensitive to environmental or foreign stim...查看全文

LAES1682021-02-19 04:56

$BELLUS Health(BLU)$ 上车查看全文

常春藤医药2021-02-04 15:52

$BELLUS Health(BLU)$ 低调上车查看全文

美股异动 | BELLUS Health(BLU.US)涨8.33% 2b期临床试验结果良好

格隆汇2月24日丨BELLUS Health(BLU.US)涨8.33%，报6.5美元。该公司昨日宣布2b期缓解顽固性慢性咳嗽(RCC)临床试验的结果良好，使BLU-5937成为潜在的同类最佳P2X3拮抗剂。该公司计划在第二季度请求食品和药物管理局(FDA)临床三期前会议，并在2022年下半年启动... 网页链接

其他

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075891  Act: 33  Size: 21 KB 网页链接

其他

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075894  Act: 33  Size: 21 KB 网页链接

其他

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075865  Act: 33  Size: 21 KB 网页链接

其他

$BELLUS Health(BLU)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000434  Act: 34  Size: 2 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-075744  Act: 34  Size: 28 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-075656  Act: 34  Size: 34 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-072257  Act: 34  Size: 38 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-068517  Act: 34  Size: 457 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-067581  Act: 34  Size: 740 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-062771  Act: 34  Size: 5 MB 网页链接